BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22296404)

  • 21. The use of SmartPill for gastric monitoring.
    Hasler WL
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):587-600. PubMed ID: 24881810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resolving the physiological conditions in bioavailability and bioequivalence studies: Comparison of fasted and fed state.
    Schneider F; Grimm M; Koziolek M; Modeß C; Dokter A; Roustom T; Siegmund W; Weitschies W
    Eur J Pharm Biopharm; 2016 Nov; 108():214-219. PubMed ID: 27639346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimally invasive wireless motility capsule to study canine gastrointestinal motility and pH.
    Warrit K; Boscan P; Ferguson LE; Bradley AM; Dowers KL; Rao S; Twedt DC
    Vet J; 2017 Sep; 227():36-41. PubMed ID: 29031328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Wireless Motility Capsule: a One-Stop Shop for the Evaluation of GI Motility Disorders.
    Saad RJ
    Curr Gastroenterol Rep; 2016 Mar; 18(3):14. PubMed ID: 26908282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional gastrointestinal contractility parameters using the wireless motility capsule: inter-observer reproducibility and influence of age, gender and study country.
    Farmer AD; Wegeberg AL; Brock B; Hobson AR; Mohammed SD; Scott SM; Bruckner-Holt CE; Semler JR; Hasler WL; Hellström PM; Drewes AM; Brock C
    Aliment Pharmacol Ther; 2018 Feb; 47(3):391-400. PubMed ID: 29210098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SmartPill® as an objective parameter for determination of severity and duration of postoperative ileus: study protocol of a prospective, two-arm, open-label trial (the PIDuSA study).
    Vilz TO; Pantelis D; Lingohr P; Fimmers R; Esmann A; Randau T; Kalff JC; Coenen M; Wehner S
    BMJ Open; 2016 Jul; 6(7):e011014. PubMed ID: 27401360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation.
    Rao SS; Kuo B; McCallum RW; Chey WD; DiBaise JK; Hasler WL; Koch KL; Lackner JM; Miller C; Saad R; Semler JR; Sitrin MD; Wilding GE; Parkman HP
    Clin Gastroenterol Hepatol; 2009 May; 7(5):537-44. PubMed ID: 19418602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of food on gastrointestinal transit of liquids in cynomolgus monkeys.
    Kondo H; Watanabe T; Yokohama S; Watanabe J
    Biopharm Drug Dispos; 2003 May; 24(4):141-51. PubMed ID: 12698497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technique for prolonged, minimally invasive monitoring of intragastric pH in ponies.
    Baker SJ; Gerring EL
    Am J Vet Res; 1993 Oct; 54(10):1725-34. PubMed ID: 8250400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of obesity on gastrointestinal transit, pressure and pH using a wireless motility capsule.
    Steenackers N; Wauters L; Van der Schueren B; Augustijns P; Falony G; Koziolek M; Lannoo M; Mertens A; Meulemans A; Raes J; Vangoitsenhoven R; Vieira-Silva S; Weitschies W; Matthys C; Vanuytsel T
    Eur J Pharm Biopharm; 2021 Oct; 167():1-8. PubMed ID: 34273543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of a hay grid feeder on feed consumption and measurement of the gastric pH using an intragastric electrode device in horses: a preliminary report.
    Aristizabal F; Nieto J; Yamout S; Snyder J
    Equine Vet J; 2014 Jul; 46(4):484-7. PubMed ID: 23991941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of gastrointestinal transit times and pH in healthy cats using a continuous pH monitoring system.
    Telles NJ; Simon BT; Scallan EM; Gould EN; Papich MG; He Y; Lee MT; Lidbury JA; Steiner JM; Kathrani A; Katherine Tolbert M
    J Feline Med Surg; 2022 Oct; 24(10):954-961. PubMed ID: 34878315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Objective evaluation of small bowel and colonic transit time using pH telemetry in athletes with gastrointestinal symptoms.
    Rao KA; Yazaki E; Evans DF; Carbon R
    Br J Sports Med; 2004 Aug; 38(4):482-7. PubMed ID: 15273191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of extensive resection of the small intestine in the pony.
    Tate LP; Ralston SL; Koch CM; Everitt JI
    Am J Vet Res; 1983 Jul; 44(7):1187-91. PubMed ID: 6881658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile.
    Farmer AD; Pedersen AG; Brock B; Jakobsen PE; Karmisholt J; Mohammed SD; Scott SM; Drewes AM; Brock C
    Diabetologia; 2017 Apr; 60(4):709-718. PubMed ID: 28105520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the effects of the opioid agonist morphine on gastrointestinal tract function in horses.
    Boscan P; Van Hoogmoed LM; Farver TB; Snyder JR
    Am J Vet Res; 2006 Jun; 67(6):992-7. PubMed ID: 16740092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Laparoscopic-assisted Gastropexy on Gastrointestinal Transit Time in Dogs.
    Balsa IM; Culp WTN; Drobatz KJ; Johnson EG; Mayhew PD; Marks SL
    J Vet Intern Med; 2017 Nov; 31(6):1680-1685. PubMed ID: 28940749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology.
    Sarosiek I; Selover KH; Katz LA; Semler JR; Wilding GE; Lackner JM; Sitrin MD; Kuo B; Chey WD; Hasler WL; Koch KL; Parkman HP; Sarosiek J; McCallum RW
    Aliment Pharmacol Ther; 2010 Jan; 31(2):313-22. PubMed ID: 19814743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behaviour and transit of tamsulosin Oral Controlled Absorption System in the gastrointestinal tract.
    Stevens HN; Speakman M
    Curr Med Res Opin; 2006 Dec; 22(12):2323-8. PubMed ID: 17257446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.